These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 2596452)
21. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases. Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848 [TBL] [Abstract][Full Text] [Related]
22. Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy. Dooley CP; McKenna D; Humphreys H; Bourke S; Keane CT; Sweeney E; O'Morain C Am J Gastroenterol; 1988 Mar; 83(3):278-82. PubMed ID: 3344730 [TBL] [Abstract][Full Text] [Related]
23. In vivo susceptibility of Campylobacter pylori. Graham DY; Klein PD; Opekun AR; Smith KE; Polasani RR; Evans DJ; Evans DG; Alpert LC; Michaletz PA; Yoshimura HH Am J Gastroenterol; 1989 Mar; 84(3):233-8. PubMed ID: 2919580 [TBL] [Abstract][Full Text] [Related]
24. Reversal of fundic atrophy after eradication of Helicobacter pylori. Tucci A; Poli L; Tosetti C; Biasco G; Grigioni W; Varoli O; Mazzoni C; Paparo GF; Stanghellini V; Caletti G Am J Gastroenterol; 1998 Sep; 93(9):1425-31. PubMed ID: 9732919 [TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis. Tan WC; Hogan J; Purkayastha SK; Lombard M; Krasner N Int J Clin Pract; 1997 Jun; 51(4):214-6. PubMed ID: 9287260 [TBL] [Abstract][Full Text] [Related]
26. Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study. Louw JA; Young GO; Lucke W; Bridger S; Winter TA; Marks IN Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):363-7. PubMed ID: 9789128 [TBL] [Abstract][Full Text] [Related]
27. [Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy]. Rühl GH; Börsch G Pathologe; 1989 Jan; 10(1):64-5. PubMed ID: 2922381 [No Abstract] [Full Text] [Related]
28. Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal disease. Cheng EH; Bermanski P; Silversmith M; Valenstein P; Kawanishi H Arch Intern Med; 1989 Jun; 149(6):1373-5. PubMed ID: 2730254 [TBL] [Abstract][Full Text] [Related]
29. Duodenal bulb biopsy findings for patients with non-ulcer dyspepsia with or without Campylobacter pylori gastritis. Frierson HF; Caldwell SH; Marshall BJ Mod Pathol; 1990 May; 3(3):271-6. PubMed ID: 2362937 [TBL] [Abstract][Full Text] [Related]
30. Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin. Glupczynski Y; Burette A; Labbe M; Deprez C; De Reuck M; Deltenre M Am J Gastroenterol; 1988 Apr; 83(4):365-72. PubMed ID: 3279757 [TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia. Koskenpato J; Färkkilä M; Sipponen P Scand J Gastroenterol; 2002 Jul; 37(7):778-84. PubMed ID: 12190090 [TBL] [Abstract][Full Text] [Related]
33. [The effect of colloidal bismuth and its combination with amoxicillin on the elimination of Helicobacter pylori in patients with a duodenal ulcer and chronic antral gastritis]. Piubello W; Aimo G; Soldinger E; Pistoso S; Raggi G; Superti G; Bonesi R; Vitali E Recenti Prog Med; 1993 Jan; 84(1):40-4. PubMed ID: 8430249 [TBL] [Abstract][Full Text] [Related]
35. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin. Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672 [TBL] [Abstract][Full Text] [Related]
36. Campylobacter pylori in upper digestive tract diseases in children. Celińska-Cedro D; Socha J; Teisseyre M Mater Med Pol; 1989; 21(4):259-62. PubMed ID: 2489238 [TBL] [Abstract][Full Text] [Related]
37. Influence of bacterial CagA status on gastritis, gastric function indices, and pattern of symptoms in H. pylori-positive dyspeptic patients. Parente F; Imbesi V; Maconi G; Cucino C; Sangaletti O; Vago L; Bianchi Porro G Am J Gastroenterol; 1998 Jul; 93(7):1073-9. PubMed ID: 9672333 [TBL] [Abstract][Full Text] [Related]
38. Indications for treatment of Helicobacter pylori infection: a systematic overview. Veldhuyzen van Zanten SJ; Sherman PM CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341 [TBL] [Abstract][Full Text] [Related]
39. Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study. Labenz J; Stolte M; Peitz U; Tillenburg B; Köhl H; Becker T; Börsch G Z Gastroenterol; 1995 Oct; 33(10):590-3. PubMed ID: 7502551 [TBL] [Abstract][Full Text] [Related]
40. Helicobacter heilmannii gastritis: association with acid peptic diseases and comparison with Helicobacter pylori gastritis. Jhala D; Jhala N; Lechago J; Haber M Mod Pathol; 1999 May; 12(5):534-8. PubMed ID: 10349993 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]